DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma

References

• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-1
   PubMed Web of Science ®Google Scholar
• Wesseling P, Capper D. WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol. 2018;44(2):139–150. doi:10.1111/nan.12432
   PubMed Web of Science ®Google Scholar
• Adilijiang A, Hirano M, Okuno Y, et al. Next generation sequencing-based transcriptome predicts bevacizumab efficacy in combination with temozolomide in glioblastoma. Molecules. 2019;24(17):3046. doi:10.3390/molecules24173046
   PubMed Web of Science ®Google Scholar
• Itoh T, Fairall L, Muskett FW, et al. Structural and functional characterization of a cell cycle associated HDAC1/2 complex reveals the structural basis for complex assembly and nucleosome targeting. Nucleic Acids Res. 2015;43(4):2033–2044. doi:10.1093/nar/gkv068
   PubMed Web of Science ®Google Scholar
• Yamashita N, Shimazaki N, Ibe S, et al. Terminal deoxynucleotidyltransferase directly interacts with a novel nuclear protein that is homologous to p65. Genes Cells. 2001;6(7):641–652. doi:10.1046/j.1365-2443.2001.00449.x
   PubMed Web of Science ®Google Scholar
• Farooqi AA, Fuentes-Mattei E, Fayyaz S, et al. Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer. Semin Cancer Biol. 2019;58:47–55. doi:10.1016/j.semcancer.2019.02.003
   PubMed Web of Science ®Google Scholar
• Mrakovcic M, Bohner L, Hanisch M, et al. Epigenetic targeting of autophagy via HDAC inhibition in tumor cells: role of p53. Int J Mol Sci. 2018;19(12):3952. doi:10.3390/ijms19123952
   PubMed Web of Science ®Google Scholar
• Bantscheff M, Hopf C, Savitski MM, et al. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol. 2011;29(3):255–265. doi:10.1038/nbt.1759
   PubMed Web of Science ®Google Scholar
• Sawai Y, Kasamatsu A, Nakashima D, et al. Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer. Lab Invest. 2018;98(8):980–988. doi:10.1038/s41374-018-0070-3
   PubMed Web of Science ®Google Scholar
• Kuriakose S, Onyilagha C, Singh R, et al. TLR-2 and MyD88-dependent activation of MAPK and STAT proteins regulates proinflammatory cytokine response and immunity to experimental trypanosoma congolense infection. Front Immunol. 2019;10:2673. doi:10.3389/fimmu.2019.02673
   PubMed Web of Science ®Google Scholar
• Yu S, Hu Q, Fan K, et al. CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling. J Cell Commun Signal. 2021;15(3):383–392. doi:10.1007/s12079-021-00619-1
   PubMed Web of Science ®Google Scholar
• Han JH, Yoon JS, Chang D-Y, et al. CXCR4-STAT3 axis plays a role in tumor cell infiltration in an orthotopic mouse glioblastoma model. Mol Cells. 2020;43(6):539–550. doi:10.14348/molcells.2020.0098
   PubMed Web of Science ®Google Scholar
• Cao R, Wang G, Qian K, et al. Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop. J Cancer. 2017;8(12):2282–2295. doi:10.7150/jca.19967
   PubMed Web of Science ®Google Scholar
• Liu Y-J, Zeng S-H, Hu Y-D, et al. Overexpression of NREP promotes migration and invasion in gastric cancer through facilitating epithelial-mesenchymal transition. Front Cell Dev Biol. 2021;9:746194. doi:10.3389/fcell.2021.746194
   PubMed Web of Science ®Google Scholar
• Yang Z, Li H, Luo P, et al. UNC5B promotes vascular endothelial cell senescence via the ROS-mediated P53 pathway. Oxid Med Cell Longev. 2021;2021:5546711. doi:10.1155/2021/5546711
   PubMed Web of Science ®Google Scholar
• Serrano-Garrido O, Peris-Torres C, Redondo-García S, et al. ADAMTS1 supports endothelial plasticity of glioblastoma cells with relevance for glioma progression. Biomolecules. 2020;11(1):44. doi:10.3390/biom11010044
   PubMed Web of Science ®Google Scholar
• Tan YQ, Li YT, Yan TF, et al. Six immune associated genes construct prognostic model evaluate low-grade glioma. Front Immunol. 2020;11:606164. doi:10.3389/fimmu.2020.606164
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. doi:10.1126/scisignal.2004088
   PubMed Web of Science ®Google Scholar
• Ranstam J, Cook JA, Ranstam J, Cook JA. Kaplan-Meier curve. Br J Surg. 2017;104(4):442. doi:10.1002/bjs.10238
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-6
   PubMed Web of Science ®Google Scholar
• Kawada J-I, Takeuchi S, Imai H, et al. Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT. J Cardiol. 2021;77(2):174–178. doi:10.1016/j.jjcc.2020.08.004
   PubMed Web of Science ®Google Scholar
• Fang Y, Huang S, Han L, et al. Comprehensive analysis of peritoneal metastasis sequencing data to identify LINC00924 as a prognostic biomarker in gastric cancer. Cancer Manag Res. 2021;13:5599–5611. doi:10.2147/CMAR.S318704
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XB, Sang XT. Development and verification of the hypoxia-related and immune-associated prognosis signature for hepatocellular carcinoma. J Hepatocell Carcinoma. 2020;7:315–330. doi:10.2147/JHC.S272109
   PubMed Web of Science ®Google Scholar
• Zeng WJ, Cheng Q, Wen Z-P, et al. Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas. J Cell Mol Med. 2020;24(17):9613–9626. doi:10.1111/jcmm.15435
   PubMed Web of Science ®Google Scholar
• Sturm D, Pfister SM, Jones DTW. Pediatric gliomas: current concepts on diagnosis, biology, and clinical management. J Clin Oncol. 2017;35(21):2370–2377. doi:10.1200/JCO.2017.73.0242
   PubMed Web of Science ®Google Scholar
• Tang W, Fan W, Lau J, et al. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem Soc Rev. 2019;48(11):2967–3014. doi:10.1039/c8cs00805a
   PubMed Web of Science ®Google Scholar
• Drexler HG, Sperling C, Ludwig WD. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia. Leukemia. 1993;7(8):1142–1150.
   PubMed Web of Science ®Google Scholar
• Patel KP, Khokhar FA, Muzzafar T, et al. TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation. Mod Pathol. 2013;26(2):195–203. doi:10.1038/modpathol.2012.142
   PubMed Web of Science ®Google Scholar
• Di Santo R, Maga G. Human terminal deoxynucleotidyl transferases as novel targets for anticancer chemotherapy. Curr Med Chem. 2006;13(20):2353–2368. doi:10.2174/092986706777935087
   PubMed Web of Science ®Google Scholar
• Shi Z, Chen Q, Li C, et al. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras. Neuro Oncol. 2014;16(10):1341–1353. doi:10.1093/neuonc/nou084
   PubMed Web of Science ®Google Scholar
• Plate KH, Scholz A, Dumont DJ. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathol. 2012;124(6):763–775. doi:10.1007/s00401-012-1066-5
   PubMed Web of Science ®Google Scholar
• Marchand M, Monnot C, Muller L, et al. Extracellular matrix scaffolding in angiogenesis and capillary homeostasis. Semin Cell Dev Biol. 2019;89:147–156. doi:10.1016/j.semcdb.2018.08.007
   PubMed Web of Science ®Google Scholar
• Ferrer VP, Moura Neto V, Mentlein R. Glioma infiltration and extracellular matrix: key players and modulators. Glia. 2018;66(8):1542–1565. doi:10.1002/glia.23309
   PubMed Web of Science ®Google Scholar
• Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci. 2016;19(1):20–27. doi:10.1038/nn.4185
   PubMed Web of Science ®Google Scholar
• Wei J, Chen P, Gupta P, et al. Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications. Neuro Oncol. 2020;22(2):180–194. doi:10.1093/neuonc/noz212
   PubMed Web of Science ®Google Scholar
• Wick W, Platten M, Wick A, et al. Current status and future directions of anti-angiogenic therapy for gliomas. Neuro Oncol. 2016;18(3):315–328. doi:10.1093/neuonc/nov180
   PubMed Web of Science ®Google Scholar
• Segura-Collar B, Garranzo-Asensio M, Herranz B, et al. Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas. Cancer Res. 2021;81(8):2142–2156. doi:10.1158/0008-5472.CAN-20-3558
   PubMed Web of Science ®Google Scholar
• Zhu C, Kros JM, Cheng C, et al. The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies. Neuro Oncol. 2017;19(11):1435–1446. doi:10.1093/neuonc/nox081
   PubMed Web of Science ®Google Scholar
• Daubon T, Hemadou A, Romero Garmendia I, et al. Glioblastoma immune landscape and the potential of new immunotherapies. Front Immunol. 2020;11:585616. doi:10.3389/fimmu.2020.585616
   PubMed Web of Science ®Google Scholar
• Skvortsova K, Stirzaker C, Taberlay P, Blewitt M. The DNA methylation landscape in cancer. Essays Biochem. 2019;63(6):797–811. doi:10.1042/EBC20190037
   PubMed Web of Science ®Google Scholar